Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
The American Journal of Psychiatry
|
August 1, 1990
Bupropion treatment of attention-deficit hyperactivity disorder in adults
P H Wender, F W Reimherr
The American Journal of Psychiatry
|
January 1, 1983
The prevalence of attention deficit disorder, residual type, or minimal brain dysfunction, in a population of male alcoholic patients
D Wood, P H Wender, F W Reimherr
Psychiatry Research
|
November 1, 1989
The introductory placebo washout: a retrospective evaluation
F W Reimherr, M F Ward, W F Byerley
Archives of General Psychiatry
|
August 1, 1985
Stimulant therapy of 'adult hyperactivity'
P H Wender, F W Reimherr, D R Wood
Psychopharmacology Bulletin
|
January 1, 1985
Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults
P H Wender, D R Wood, F W Reimherr
Archives of General Psychiatry
|
April 1, 1981
Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment
P H Wender, F W Reimherr, D R Wood
The American Journal of Psychiatry
|
June 1, 1993
The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder
M F Ward, P H Wender, F W Reimherr
Psychopharmacology Bulletin
|
January 1, 1985
Amino acid precursors for the treatment of attention deficit disorder, residual type
D R Wood, F W Reimherr, P H Wender
The American Journal of Psychiatry
|
January 1, 1980
An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction
F W Reimherr, D R Wood, P H Wender
Psychopharmacology Bulletin
|
January 1, 1986
The use of MK-801, a novel sympathomimetic, in adults with attention deficit disorder, residual type
F W Reimherr, D R Wood, P H Wender
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
The American Journal of Psychiatry
|
August 1, 1990
Bupropion treatment of attention-deficit hyperactivity disorder in adults
P H Wender, F W Reimherr
The American Journal of Psychiatry
|
January 1, 1983
The prevalence of attention deficit disorder, residual type, or minimal brain dysfunction, in a population of male alcoholic patients
D Wood, P H Wender, F W Reimherr
Psychiatry Research
|
November 1, 1989
The introductory placebo washout: a retrospective evaluation
F W Reimherr, M F Ward, W F Byerley
Archives of General Psychiatry
|
August 1, 1985
Stimulant therapy of 'adult hyperactivity'
P H Wender, F W Reimherr, D R Wood
Psychopharmacology Bulletin
|
January 1, 1985
Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults
P H Wender, D R Wood, F W Reimherr
Archives of General Psychiatry
|
April 1, 1981
Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment
P H Wender, F W Reimherr, D R Wood
The American Journal of Psychiatry
|
June 1, 1993
The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder
M F Ward, P H Wender, F W Reimherr
Psychopharmacology Bulletin
|
January 1, 1985
Amino acid precursors for the treatment of attention deficit disorder, residual type
D R Wood, F W Reimherr, P H Wender
The American Journal of Psychiatry
|
January 1, 1980
An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction
F W Reimherr, D R Wood, P H Wender
Psychopharmacology Bulletin
|
January 1, 1986
The use of MK-801, a novel sympathomimetic, in adults with attention deficit disorder, residual type
F W Reimherr, D R Wood, P H Wender
Page
of 4